NCT01115803 2019-02-05A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Terminated29 enrolled 19 charts
NCT00096486 2016-01-21Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung CancerMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed74 enrolled 9 charts